440 filings
Page 5 of 22
DEFA14A
1jg7aihygrbj84y3y6n
3 Jun 22
Additional proxy soliciting materials
6:06am
8-K
kp3wu
2 Jun 22
Termination of a Material Definitive Agreement
5:25pm
8-K
uct32n 3y132ol
16 May 22
AcelRx Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:35am
8-K
rqbstbwpgy su
9 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:21pm
EFFECT
eas4tedf854uc5
4 May 22
Notice of effectiveness
12:15am
424B7
f0xbojmlnfl04ungcsnu
3 May 22
Prospectus with selling stockholder info
5:24pm
8-K
nmcsfpr a5iufv
31 Mar 22
Other Events
4:05pm
8-K
1gcmnyw5ccn ylo
10 Mar 22
AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
4:06pm
8-K
lnu vz79zj
1 Mar 22
Departure of Directors or Certain Officers
4:10pm
8-K
8jfkl
14 Feb 22
Departure of Directors or Certain Officers
12:00am
D
tv90br
24 Jan 22
$5.96M in equity, sold $5.16M, 32 investors
4:21pm
8-K
hnrh2
12 Jan 22
AcelRx Pharmaceuticals Announces the Closing of its Acquisition of Lowell Therapeutics
4:01pm
8-K
torvt21zlbvpepd3jq1
3 Dec 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:48pm